This review summarizes the role of the NLRP3 inflammasome in the mechanisms of CVD-depression comorbidity and explores the potential and challenges of targeting the NLRP3 inflammasome for the treatment of this condition. The gene discussed is NLRP3; the disease is depressive symptom measurement.